B95.5

⚕️ICD-10-CM Code: B95.5 - Unspecified streptococcus as the cause of diseases classified elsewhere

Unspecified streptococcus as the cause of diseases classified elsewhere

B95.5 - Unspecified streptococcus as the cause of diseases classified elsewhere:

Explanation: Code B95.5 functions strictly as a secondary, supplemental adjunct diagnostic classification. It is utilized exclusively to identify a generic streptococcal bacterial etiologic agent responsible for an infectious disease process that is anatomically categorized within an alternate chapter of the ICD-10-CM nosological framework. The utilization of this code as a primary or principal diagnosis is strictly contraindicated under all universally accepted medical coding conventions. Its application is reserved exclusively for clinical scenarios wherein the diagnostic code for the primary condition (which denotes the anatomical manifestation or localized site of the infection) lacks inherent specification of the causative organism, and the attending clinician has definitively documented a streptococcal etiology without specifying the precise taxonomic group, species, or serotype (e.g., failing to differentiate between Group A, Group B, Streptococcus pneumoniae, or Viridans group streptococci).

Clinically, the application of an “unspecified” organism code frequently occurs in the acute or preliminary phases of patient care, specifically prior to the finalization of definitive microbiological culture and sensitivity (C&S) laboratory reports. A physician may empirically diagnose and document a “streptococcal skin infection” based purely on classical clinical presentation (such as the distinct, demarcated erythema characteristic of erysipelas) and initiate broad-spectrum or empiric antimicrobial therapy before pathogen serotyping is available.

However, from an epidemiological, public health, and health administration perspective, the longitudinal deployment of unspecified codes such as B95.5 is inherently problematic. While procedurally valid when clinical documentation is limited, the pervasive use of unspecified pathogen codes degrades the granularity of public health databases, obscuring vital epidemiological trends related to pathogen prevalence, antimicrobial resistance patterns, and disease outbreak tracking. Furthermore, in the contemporary era of precision medicine and value-based purchasing, health systems actively discourage the final coding of unspecified organisms upon patient discharge. Consequently, B95.5 represents a primary target for Clinical Documentation Integrity (CDI) interventions, as its presence frequently signals incomplete clinical synthesis within the electronic medical record (EMR). Methodologically, the application of B95.5 fulfills the mandatory “Use additional code to identify organism” instructional notations pervasive throughout the organ-system chapters of the tabular list, albeit with the lowest possible level of clinical specificity1.

Top Related/Alternative Codes

In optimal clinical environments, the generic utilization of B95.5 should be rigorously minimized. Whenever definitive microbiological identification (e.g., via Lancefield antigen grouping, precise hemolysis patterns, or polymerase chain reaction assay) is achieved and documented by the attending physician, the following highly specific alternative classifications must be utilized to replace B95.5:

• B95.0 - Streptococcus, group A, as the cause of diseases classified elsewhere: The mandatory selection when clinical documentation specifies Group A Streptococcus (e.g., Streptococcus pyogenes). This pathogen is synonymous with severe, rapidly advancing soft tissue infections, acute rheumatic fever, and post-streptococcal glomerulonephritis.

• B95.1 - Streptococcus, group B, as the cause of diseases classified elsewhere: The required code for the identification of Group B Streptococcus (e.g., Streptococcus agalactiae). This classification is indispensable in the contexts of neonatal early-onset sepsis, peripartum maternal chorioamnionitis, and specific invasive infections impacting immunocompromised or diabetic adult populations.

• B95.2 - Enterococcus as the cause of diseases classified elsewhere: Assigned to denote infections of an enterococcal etiology (e.g., Enterococcus faecalis, Enterococcus faecium). Though historically classified as Group D streptococci, they are microbiologically distinct and critical to identify due to their propensity for profound antimicrobial resistance (e.g., VRE).

• B95.3 - Streptococcus pneumoniae as the cause of diseases classified elsewhere: Appropriate for the specific clinical documentation of pneumococcal infections acting as the primary etiology for secondary anatomical manifestations outside the pulmonary system, such as pneumococcal meningitis or hematogenous osteomyelitis.

• B95.4 - Other streptococcus as the cause of diseases classified elsewhere: Utilized when documentation confirms specific atypical strains, most notably the Viridans group streptococci, Streptococcus bovis, or Group C/G streptococci.

• A41.59 - Sepsis due to other Gram-positive organisms: (Note: Sepsis due to unspecified streptococcus routes to this code or A41.9 depending on index navigation, but specific sepsis combination codes preclude the use of B-series etiology codes). A comprehensive combination code utilized for patients presenting with confirmed systemic inflammatory response syndrome (SIRS) driven by an unspecified gram-positive pathogen.

Code Tree (Hierarchy)

The hierarchical structure of the ICD-10-CM classification system meticulously isolates the categorization of infectious agents from the localized anatomical sites they infect, adhering to the dual-coding etiology/manifestation convention:

• Chapter 1: Certain infectious and parasitic diseases (A00-B99)

  • Block: Bacterial and viral infectious agents (B95-B97)

    • Category: Streptococcus, Staphylococcus, and Enterococcus as the cause of diseases classified elsewhere (B95)

      • Specific Code: B95.5 (Unspecified streptococcus as the cause of diseases classified elsewhere)

This structural paradigm explicitly dictates that Category B95 functions solely as a repository for etiologic agents acting as secondary, adjunctive descriptors. These codes cannot stand alone; they exist solely to provide essential microbiological granularity to primary localizing pathologies located in disparate chapters of the manual (e.g., Chapter 12 for Diseases of the Skin and Subcutaneous Tissue).

Exclusives/Inclusives

• Includes:

  • Infectious disease processes definitively attributed to a streptococcal pathogen, wherein the specific taxonomic strain, serogroup, or species is explicitly stated as “unspecified,” “unknown,” or is entirely absent from the physician’s clinical documentation.

  • Diagnoses documented as “Streptococcal infection NOS (Not Otherwise Specified)” affecting a specific, identified anatomical site.

• Excludes1 (Mutually Exclusive - Cannot be coded together):

  • Sepsis due to unspecified streptococcus (A41.9 or A41.59 depending on precise documentation parameters)

  • Streptococcal infection, unspecified site (A49.1)

  • Streptococcal pharyngitis (J02.0)

  • Scarlet fever (A38.9)

  • Explanation: The operational principle of the Excludes1 edit is grounded in strict diagnostic mutual exclusivity. The aforementioned conditions are represented by specific combination codes or designated broad categories that already inherently incorporate the “streptococcus” organism within their foundational diagnostic definitions, or, in the case of A49.1, represent an infection where the anatomical site itself is unknown. Consequently, the dual application of B95.5 alongside these specific combination codes violates the foundational principle of coding parsimony. Such dual reporting constitutes an explicit Excludes1 instructional violation, rendering the coding sequence procedurally invalid and universally triggering automated clearinghouse claim denials.

Reimbursement & Clinical Documentation Indicators

• HCC Information: Code B95.5, evaluated in strict isolation, does not map to a Hierarchical Condition Category (HCC) within the CMS-HCC risk adjustment methodology utilized for Medicare Advantage reimbursement. The applicable HCC risk score and corresponding financial weight remain entirely contingent upon the primary diagnosis code (e.g., severe localized cellulitis, acute mastoiditis) to which B95.5 is appended. However, unlike highly specific organism codes (such as those identifying VRE or MRSA), the deployment of an “unspecified” code provides minimal robust defense during retrospective Risk Adjustment Data Validation (RADV) audits, as it reflects a lack of definitive diagnostic clarity regarding the complexity of the patient’s condition2.

• MS-DRG and APR-DRG Impacts: Within contemporary iterations of the Medicare Severity Diagnosis Related Groups (MS-DRG) grouper software, B95.5 frequently functions as a standard diagnosis and generally does not achieve the designation of a CC (Complication or Comorbidity) or MCC (Major Complication or Comorbidity) in the same manner that a definitively specified, highly resistant pathogen might. Its impact on the final inpatient MS-DRG assignment is therefore typically neutral, failing to trigger a DRG shift to a higher, more heavily weighted tier. Similarly, within the All Patient Refined Diagnosis Related Groups (APR-DRG) system, an “unspecified” bacterial pathogen generally fails to elevate the Severity of Illness (SOI) and Risk of Mortality (ROM) subclasses to the maximum extent possible, potentially resulting in reduced institutional reimbursement that does not accurately reflect the hospital resource consumption required for patient management3.

• Clinical Documentation Integrity (CDI) Requisites and Query Protocols: Code B95.5 is considered a “red flag” within comprehensive Clinical Documentation Integrity programs. It is a foundational tenet of medical coding ethics that pathology and microbiology laboratory results cannot be independently interpreted by the coding professional. If the patient’s EMR contains a finalized microbiology report confirming Streptococcus pneumoniae or Group A Streptococcus, but the attending clinician merely documented “Streptococcal pneumonia” or “Strep cellulitis” in the discharge summary, the coder cannot bypass the physician’s documentation to assign the specific code. In this ubiquitous scenario, the CDI specialist or coder is strictly obligated to issue a compliant, non-leading query to the provider. The query must present the clinical laboratory findings and respectfully request that the physician clarify and document the definitive specific organism responsible for the localized infection, thereby preventing the erroneous and financially detrimental final assignment of B95.51.

CPT/HCPCS Specific Information

(Note: Given that B95.5 represents an alphanumeric ICD-10-CM diagnosis classification utilized to comprehensively demonstrate medical necessity and disease etiology, rather than a distinct procedural intervention performed by a provider, direct CPT/HCPCS procedural metrics such as Relative Value Units are clinically inapplicable. However, the diagnosis code fundamentally supports the medical necessity for associated diagnostic procedures.)

• CPT/HCPCS Code(s): N/A (Directly). Nevertheless, the presence of B95.5 strongly supports the medical necessity for related diagnostic, therapeutic, and laboratory CPT codes, including but not limited to:

  • 87880 - Infectious agent antigen detection by immunoassay with direct optical observation; Streptococcus, group A (Rapid Strep Test). (Note: Often performed empirically before definitive classification).

  • 87081 - Culture, presumptive, pathogenic organisms, screening only.

  • 87070 - Culture, bacterial; any other source except urine, blood or stool, aerobic, with isolation and presumptive identification of isolates.

• WRVU: N/A

• Global periods: N/A

• Assistant Payable: N/A

• Bundling & NCCI Edits: N/A

Coding Examples

Example 1: Acute Cellulitis (Empiric Treatment)

• Clinical Scenario: A 35-year-old patient presents to an outpatient urgent care clinic with severe, rapidly spreading erythema, induration, and warmth on the left lower leg. The attending physician diagnoses the patient with acute cellulitis. Based on the classic physical presentation, the physician suspects a streptococcal etiology and documents “Acute cellulitis of the left lower extremity, highly likely streptococcal.” The physician prescribes a course of empiric oral cephalexin. No wound cultures are obtained as there is no purulent exudate to swab.

• Coding:

  • Primary: L03.116 (Cellulitis of left lower limb)

  • Secondary: B95.5 (Unspecified streptococcus as the cause of diseases classified elsewhere)

• Rationale: The L03.116 code accurately identifies the primary anatomical manifestation and localized inflammatory process. Because the physician explicitly documented a streptococcal etiology, but did not (and clinically could not, lacking a culture) specify the precise taxonomic group or strain, the supplementary addition of B95.5 is the most accurate reflection of the documented clinical scenario.

Example 2: CDI Query Opportunity (Missing Documentation of Lab Results)

• Clinical Scenario: An elderly patient is admitted to the inpatient ward for severe acute pyelonephritis. Urine cultures are drawn upon admission. By day three, the finalized microbiology report identifies a heavy growth of Streptococcus agalactiae (Group B Strep). However, the attending physician’s discharge summary simply states, “Acute pyelonephritis secondary to streptococcal infection; resolved with IV ceftriaxone.”

• Coding Process & Query:

  • Initial Incorrect Coding Route: Relying solely on the discharge summary, a coder would be forced to assign N15.9 (Renal tubulo-interstitial disease, unspecified - often used for generic pyelonephritis NOS) paired with B95.5 (Unspecified streptococcus).

  • CDI Intervention: The coder reviews the EMR, identifies the finalized culture results, and issues a compliant query: “Dr. Smith, the discharge summary documents ‘streptococcal infection’ as the etiology for the acute pyelonephritis. Laboratory results from 10/24 note the presence of Streptococcus agalactiae (Group B). Can you please clarify the specific organism responsible for the pyelonephritis?”

  • Final Correct Coding (Post-Query): Following the physician’s addendum confirming Group B Streptococcus, the final coding is updated. Primary: N15.9, Secondary: B95.1 (Streptococcus, group B, as the cause of diseases classified elsewhere).

• Rationale: This illustrates the critical limitations of B95.5. It represents a failure of clinical documentation integrity when definitive microbiological data exists but remains unsynthesized by the provider.

Example 3: Acute Mastoiditis with Pending Microbiology

• Clinical Scenario: A pediatric patient is admitted through the emergency department with acute mastoiditis without complications. The ENT surgeon performs a tympanocentesis to relieve pressure and sends the fluid for culture. At the time of interim billing, the culture results remain pending (labeled as “preliminary gram-positive cocci in chains”). The physician documents “Acute mastoiditis, presumptive streptococcal etiology pending final cultures.”

• Coding:

  • Primary: H70.009 (Acute mastoiditis without complications, unspecified ear) (Note: Laterality should ideally be queried if unspecified).

  • Secondary: B95.5 (Unspecified streptococcus as the cause of diseases classified elsewhere)

• Rationale: Because the medical record must be coded based on the documentation available at the time of the encounter or interim billing cycle, and the physician has definitively documented a presumptive streptococcal infection without specifying the exact strain, B95.5 is appropriate. Should the cultures eventually return positive for S. pneumoniae, the coding could potentially be amended upon final review.

Example 4: Counter-Example (Improper Usage - Unspecified Site vs. Unspecified Organism)

• Clinical Scenario: A patient presents via telehealth with systemic malaise, low-grade fever, and generalized myalgia. The physician suspects a mild systemic bacterial infection but cannot localize it to the respiratory tract, urinary tract, or skin. The physician empirically documents “Suspected generalized streptococcal infection.”

• Coding:

  • Primary: A49.1 (Streptococcal infection, unspecified site)

  • Incorrect Addition: B95.5

• Rationale: In this clinical scenario, the application of B95.5 is strictly prohibited by ICD-10-CM coding conventions. Code B95.5 is exclusively an adjunct code designed to be attached to a known localized disease classified elsewhere (e.g., pneumonia, cellulitis, osteomyelitis). When the anatomical site of the infection itself is entirely unknown, the primary diagnostic code A49.1 must be utilized. Appending B95.5 to A49.1 would be procedurally redundant and explicitly violates the Excludes1 directives governing both code categories.

Sources:

1 ICD-10-CM Official Guidelines for Coding and Reporting, Section I.C.1.b (Use of specific infectious agent codes)

2 CMS-HCC Risk Adjustment Model mappings

3 Medicare Severity Diagnosis Related Groups (MS-DRG) Definitions Manual